Press "Enter" to skip to content

Enteral Feeding Formulas Market: Future Forecast Indicates Impressive Growth Rate

According to Stratistics MRC, the Global Enteral Feeding Formulas Market is accounted for $4.29 billion in 2017 and is expected to reach $9.83 billion by 2026 growing at a CAGR of 9.7% during the forecast period. Some of the key factors influencing the market growth include rising prevalence of chronic diseases and disorders, growing geriatric population, growing number of preterm births and rising demand for homecare. However, complications associated with enteral feeding are hindering the market growth.

Enteral feeding is a method to deliver nutrients into the gastrointestinal tract through the use of a tube. It is considered when an individual is not safe for oral intake or oral intake is not adequate to meet nutritional requirements. Enteral feeding tubes are available in various types based on the feeding route such as nasal tube, oral tube and esophagostomy tube.

Amongst Product, the standard formulas segment has considerable growth during the forecast period. The growth of this segment can be attributed to their extensive use in a majority of enterally fed patients, especially chronically tube-fed patients.

By Geography, Asia-Pacific region is expected to offer significant growth opportunities for market players during the forecast period due to the presence of a large patient pool for chronic diseases and disorders, increasing incidences of preterm births, rising healthcare expenditure, rapidly developing healthcare infrastructure, increasing middle-class population and rising population in emerging APAC countries.

Request for Report Sample:

Some of the key players in global enteral feeding formulas market are Abbott Laboratories, Novartis AG, Global Health Product Inc., Nestle S.A., Trovita Health Science, Danone Nutricia, Fresenius Kabi, Hormel Foods Corporation, Meiji Holdings Co., Ltd., Mead Johnson Nutrition Company, Victius Inc., B. Braun Melsungen AG and Merck & Co., Inc.

Products Covered:
• Disease-Specific Formulas
• Standard Formulas
• Blenderized Formula
• Fiber Supplemented Formula
• Semi-Elemental Formula
• Polymeric Formula
• Elemental Formula
• Hydrolyzed Formula
• Other Products

Stages Covered:
• Pediatrics
• Adults

Forms Covered:
• Liquid
• Powder
• Other Forms

Mode of Deliveries Covered:
• Oral
• Trans-pyloric
• Gastric

Flavor Types Covered:
• Flavored
• Unflavored

Therapeutic Areas Covered:
• Malabsorption
• Crohn’s disease
• Cystic Fibrosis
• Congenital Heart Disease
• Kidney Failure
• Choanal atresia
• Inflammatory bowel disease
• Short Bowel Syndrome
• Other Therapeutic Areas

Applications Covered:
• Gastroenterology
• Diabetes
• Neurology
• Oncology
• Critical Care
• Other Applications

End Users Covered:
• Long-Term Care Facilities
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

Place a Direct Purchase Order @

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Request for Report Discount:

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *